Mucopolysaccharidosis Type I clinical trials

Explore recruiting mucopolysaccharidosis type i clinical trials.

Recruiting mucopolysaccharidosis type i studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mucopolysaccharidosis Type I trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase I/II study evaluating safety and efficacy of autologous hematopoietic stem and progenitor cells genetically modified with IDUA lentiviral vector encoding for the human α-L-iduronidase gene for the treatment of patients affected by Mucopolysaccharidosis Type I, Hurler variant

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A multi-center, randomized, active controlled clinical trial to evaluate the efficacy and safety of OTL-203 in subjects with mucopolysaccharidosis type I, Hurler syndrome (MPS-IH) compared to standard of care with allogeneic hematopoietic stem cell transplantation (allo-HSCT)

Italy, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mucopolysaccharidosis Type I trials by city

Mucopolysaccharidosis Type I in Toronto Mucopolysaccharidosis Type I in Vancouver Mucopolysaccharidosis Type I in Montreal Mucopolysaccharidosis Type I in Calgary Mucopolysaccharidosis Type I in Edmonton Mucopolysaccharidosis Type I in Ottawa Mucopolysaccharidosis Type I in Winnipeg Mucopolysaccharidosis Type I in Quebec City Mucopolysaccharidosis Type I in Hamilton Mucopolysaccharidosis Type I in Kitchener Mucopolysaccharidosis Type I in London Mucopolysaccharidosis Type I in Halifax Mucopolysaccharidosis Type I in New York Mucopolysaccharidosis Type I in Los Angeles Mucopolysaccharidosis Type I in Chicago Mucopolysaccharidosis Type I in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease